Vertex Pharmaceuticals Inc (VRTX) — Financial Flexibility Index
Vertex Pharmaceuticals Inc (VRTX) has a Financial Flexibility Index of 0.17x as of June 2026. Free cash flow of $1.24 Billion (operating CF $1.13 Billion minus capex $112.20 Million) represents 0% of total liabilities ($7.18 Billion). Check Vertex Pharmaceuticals Inc (VRTX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vertex Pharmaceuticals Inc Financial Flexibility Index (1991–2025)
Historical Financial Flexibility Index trend for Vertex Pharmaceuticals Inc across 35 annual periods. For the full cash flow conversion analysis, see Vertex Pharmaceuticals Inc (VRTX) cash conversion ratio.
Annual Financial Flexibility Index for Vertex Pharmaceuticals Inc (1991–2025)
Year-by-year free cash flow to debt coverage for Vertex Pharmaceuticals Inc. Explore VRTX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $4.07 Billion | $3.63 Billion | $7.48 Billion | ▲ +1809.8% |
| 2024 | -0.03x | $-194.90 Million | $-492.60 Million | $6.12 Billion | ▼ -104.3% |
| 2023 | 0.74x | $3.80 Billion | $3.54 Billion | $5.15 Billion | ▼ -27.9% |
| 2022 | 1.02x | $4.33 Billion | $4.13 Billion | $4.24 Billion | ▲ +18.4% |
| 2021 | 0.86x | $2.88 Billion | $2.64 Billion | $3.33 Billion | ▼ -24.6% |
| 2020 | 1.15x | $3.51 Billion | $3.25 Billion | $3.06 Billion | ▲ +55.6% |
| 2019 | 0.74x | $1.64 Billion | $1.57 Billion | $2.23 Billion | ▼ -2.4% |
| 2018 | 0.75x | $1.37 Billion | $1.27 Billion | $1.81 Billion | ▲ +2.7% |
| 2017 | 0.73x | $1.10 Billion | $844.94 Million | $1.50 Billion | ▲ +290.4% |
| 2016 | 0.19x | $292.67 Million | $236.10 Million | $1.56 Billion | ▲ +182.5% |
| 2015 | -0.23x | $-320.13 Million | $-365.43 Million | $1.40 Billion | ▲ +38.9% |
| 2014 | -0.37x | $-462.00 Million | $-513.20 Million | $1.24 Billion | ▼ -202777.7% |
| 2013 | 0.00x | $-177.00K | $-51.57 Million | $962.64 Million | ▼ -100.1% |
| 2012 | 0.22x | $338.98 Million | $267.84 Million | $1.52 Billion | ▲ +15.5% |
| 2011 | 0.19x | $238.33 Million | $143.74 Million | $1.24 Billion | ▲ +139.3% |
| 2010 | -0.49x | $-597.39 Million | $-635.44 Million | $1.22 Billion | ▼ -4.0% |
| 2009 | -0.47x | $-404.09 Million | $-427.59 Million | $859.14 Million | ▼ -79.5% |
| 2008 | -0.26x | $-194.30 Million | $-226.48 Million | $741.61 Million | ▲ +60.7% |
| 2007 | -0.67x | $-220.06 Million | $-252.48 Million | $330.18 Million | ▼ -2886.4% |
| 2006 | 0.02x | $9.94 Million | $-22.48 Million | $415.64 Million | ▲ +104.8% |
| 2005 | -0.50x | $-155.09 Million | $-172.05 Million | $309.82 Million | ▼ -96.9% |
| 2004 | -0.25x | $-129.66 Million | $-142.16 Million | $510.01 Million | ▲ +10.1% |
| 2003 | -0.28x | $-150.27 Million | $-167.62 Million | $531.57 Million | ▼ -222.5% |
| 2002 | -0.09x | $-38.32 Million | $-79.54 Million | $437.14 Million | ▼ -186.0% |
| 2001 | 0.10x | $45.83 Million | $-8.07 Million | $449.78 Million | ▲ +1019.8% |
| 2000 | -0.01x | $-4.73 Million | $-16.64 Million | $427.12 Million | ▲ +98.4% |
| 1999 | -0.67x | $-15.60 Million | $-31.80 Million | $23.21 Million | ▲ +41.8% |
| 1998 | -1.15x | $-23.20 Million | $-31.10 Million | $20.10 Million | ▼ -565.4% |
| 1997 | -0.17x | $-3.40 Million | $-9.40 Million | $19.60 Million | ▲ +93.9% |
| 1996 | -2.86x | $-36.30 Million | $-40.30 Million | $12.70 Million | ▼ -269.4% |
| 1995 | -0.77x | $-10.60 Million | $-16.00 Million | $13.70 Million | ▲ +35.3% |
| 1994 | -1.20x | $-12.80 Million | $-14.70 Million | $10.70 Million | ▼ -232.3% |
| 1993 | 0.90x | $10.40 Million | $8.60 Million | $11.50 Million | ▲ +269.0% |
| 1992 | -0.54x | $-3.80 Million | $-5.30 Million | $7.10 Million | ▼ -101.7% |
| 1991 | -0.27x | $-1.30 Million | $-2.50 Million | $4.90 Million | — |